research Telogen effluvium: Long term Covid-19 symptom
COVID-19 recovery can lead to temporary hair loss called telogen effluvium.
Search
for
Sort by
Research
330-360 / 1000+ results 
research Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.
research The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
COVID-19 might affect male fertility, but more research is needed to understand the full impact.
research Under Development JAK Inhibitors for Dermatologic Diseases
New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.
research Changing trends in surgical hair restoration: Use of Google Trends and the ISHRS practice census survey
More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.
research Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.
research Comparing minoxidil-finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials
The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.
research The pathogenesis of alopecia areata
Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.
research BH16: Trichorrhexis nodosa improving with oral minoxidil: a case report
research Referee report. For: Pathogenesis of Androgenetic alopecia [v1; indexed, http://f1000r.es/5ar]
Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.
research Referee report. For: Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study [version 1; referees: 2 approved]
Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.
research Androgenetic Alopecia
Androgenetic alopecia is the most common cause of hair loss, affecting both men and women, with varying patterns and prevalence among different races.
research Author response: Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
ILC1-like cells may contribute to hair loss in alopecia areata.
research Alteration in Asbabe-Sitta-Zaruriyah (Six essential pre-requisite for maintaining health) to prevent Intithār al-Sha‘r (Telogen Effluvium): An Insight
Changing six essential health practices can help prevent excessive hair shedding.
research Hair
Alopecia areata causes significant emotional and social challenges, especially with more hair loss.
research Five‐year experience in the treatment of alopecia areata with DPC
Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.
research Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.
research A comparative study of treatment modalities in female androgenetic alopecia
Using both minoxidil and platelet-rich plasma therapy together is more effective for hair growth in women than using minoxidil alone.
research Topical minoxidil‐induced paresthesia
Topical minoxidil can cause tingling or pricking sensations.
research Role of Growth Factors-rich Plasma (Activated Platelet-rich Plasma) in Androgenic Alopecia: Literature Review and Suggested Treatment Protocol
PRP shows promise for treating hair loss, but more research is needed.
research Evaluation of the effectiveness of fractional lasers in the treatment of androgenetic alopecia: a literature review
Fractional lasers, combined with topical therapy, are a promising and safe treatment for hair loss.
research SERUM VITAMIN D3 LEVELS IN PATIENTS WITH TELOGEN EFFLUVIUM IN DUHOK GOVERNORATE
People with telogen effluvium often have much lower vitamin D levels than healthy individuals.
research Acquired progressive kinking of the hair following COVID‐19 disease
COVID-19 can cause hair to become progressively kinked.
research Role of polymorphism of the androgen receptor gene andnon-random x chromosome inactivation in the pathogenesisof androgenic alopecia
Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.
research Genetic Analysis of Male Pattern Baldness and the 5α-Reductase Genes
Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.
research Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
research Proceedings of the Joint CHSF /HSF /EHSF pre‐WCD Hidradenitis Suppurativa Symposium
HS needs personalized treatment plans and more research.
research ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.
research Comparative Efficacy of Oral Minoxidil and Topical Minoxidil in Treating Androgenetic Alopecia: A Systematic Review and Meta-Analysis
Topical minoxidil is safer and improves hair density better than oral minoxidil.
research A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia
Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.